Fireside Chat with Dr. David Perlin

Jun 18, 2024 4:00 pm EDT

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Matinas is an emerging clinical-stage biopharmaceutical company, based in Bedminster, New Jersey. Since commencing operations in 2013, we have been working to develop novel, life-changing pharmaceutical products.

What distinguishes us is our targeted approach to therapeutics. Our technologies and products are strategically designed to overcome the limitations associated with existing therapies. Backed with biopharmaceutical expertise and practical knowledge, we can take highly effective drugs and formulate their delivery to be safer, more efficient, and even more clinically effective, with more impact in improving patients’ lives.

Our company is supported by a world-class team of clinical opinion leaders and critical collaborations with industry-leading firms. We all share an unwavering commitment to research and education in the bioscience community – particularly in the fields of lipids and infectious disease. Moving forward, we will continue to expand the depth and breadth of our disruptive platforms.

Investor Contact Information


Matinas BioPharma Holdings, Inc.
1545 Route 206 South
Suite 302
Bedminster, NJ 07921
T: 908-484-8805

Investor Relations

LHA Investor Relations
Jody Cain
T: (310) 691-7100

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: (212) 828-8436
F: (646) 536-3179